Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

Medicine & Life Sciences

• Taiwan 77%
• Progression-Free Survival 59%
• Non-Small Cell Lung Carcinoma 58%
• Retrospective Studies 52%
• Safety 45%
• Survival 36%
• Drug-Related Side Effects and Adverse Reactions 24%
• University Hospitals 20%
• pembrolizumab 18%
• Ipilimumab 18%
• Nivolumab 17%
• Clinical Trials 16%
• Prescription Drugs 15%
• National Health Programs 13%
• Exanthema 12%
• Venous Thrombosis 12%
• Nausea 11%
• Immunotherapy 11%
• Fatigue 10%
• Medical Records 10%
• Therapeutics 10%
• Hepatocellular Carcinoma 10%
• Fever 9%
• Epithelial Cells 9%
• Observation 9%
• Neoplasms 8%
• Odds Ratio 8%
• Inflammation 7%
• Incidence 6%
• Pharmaceutical Preparations 5%

Agriculture & Biology

• retrospective studies 100%
• lung neoplasms 85%
• Taiwan 76%
• clinical trials 27%
• drugs 25%
• cells 24%
• health insurance 20%
• therapeutics 20%
• neoplasms 19%
• medical records 19%
• nausea 18%
• drug toxicity 18%
• immunotherapy 17%
• odds ratio 16%
• thrombosis 15%
• hepatoma 14%
• fever 12%
• inflammation 11%
• testing 10%
• incidence 9%
• methodology 7%
• tissues 5%

Chemical Compounds

• Safety 66%
• Drug 41%